Skip to content

Author

Da Qian

We have 5 of 22 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Epigenetic regulation of NLRP3 by ACLY–PLAC8 axis sustains metabolic adaptation in triple-negative breast cancer

Cell metabolism is intricately interconnected with various pathological processes, including metabolic disorders, chronic inflammation, and tumor progression. Dysregulated lipid metabolism can result in mitochondrial dysfunction and excessive reactive oxygen species accumulation, which are well-established triggers f...

Mi-Sha Mao, Hao-Tian Liu, Jiang-Jiang Qin et al. · 0 citations
Review Open access Sep 2026

Targeted Lysosomal Degradation of Extracellular and Membrane Proteins: From Receptor Hijacking to Programmable Endolysosomal Routing

ABSTRACT Lysosome‐targeting chimeras (LYTACs) have emerged as a strategy for eliminating secreted, extracellular, and plasma‐membrane proteins by redirecting them to the endolysosomal system. By coupling target recognition to receptor‐mediated uptake, LYTACs exploit endogenous trafficking pathways to access disease‐ass...

Ke Liu, Xi-Yan Wang, Xiao-Zhen Liu et al. · 0 citations
Open access Aug 2026

A Single‐Amino‐Acid Ligand for LAT1: A Minimalist and Modular Platform for Lysosome‐Targeted Degradation of Membrane Proteins

This work establishes a synthetically accessible, truly modular, and tumor‑selective degradation platform driven by a single amino acid, offering a streamlined alternative to existing lysosome‑targeting technologies.

Li-Quan Zhu, Ke Liu, Hao-Tian Liu et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.